Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

5-HT3 Receptor Brain-Type B-Subunits are Differentially Expressed in Heterologous Systems.

Corradi J, Thompson AJ, McGonigle I, Price KL, Bouzat C, Lummis SC.

ACS Chem Neurosci. 2015 Jul 15;6(7):1158-64. doi: 10.1021/acschemneuro.5b00080. Epub 2015 May 7.

2.

A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors.

Thompson AJ, Lummis SC.

Br J Pharmacol. 2013 Sep;170(2):391-402. doi: 10.1111/bph.12287.

3.

Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.

Lochner M, Lummis SC.

Biophys J. 2010 Apr 21;98(8):1494-502. doi: 10.1016/j.bpj.2009.12.4313.

4.

Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.

Michaelson SD, Paulsen IM, Kozuska JL, Martin IL, Dunn SM.

Neuropharmacology. 2013 Oct;73:398-403. doi: 10.1016/j.neuropharm.2013.06.017. Epub 2013 Jun 26.

PMID:
23810831
5.
6.

Modulation of human 5-hydroxytryptamine type 3AB receptors by volatile anesthetics and n-alcohols.

Stevens R, Rüsch D, Solt K, Raines DE, Davies PA.

J Pharmacol Exp Ther. 2005 Jul;314(1):338-45. Epub 2005 Apr 14.

7.

Subunit-dependent inhibition and potentiation of 5-HT3 receptor by the anticancer drug, topotecan.

Nakamura Y, Ishida Y, Yamada T, Kondo M, Shimada S.

J Neurochem. 2013 Apr;125(1):7-15. doi: 10.1111/jnc.12146. Epub 2013 Jan 31.

8.

Characterization of the effects of four HTR3B polymorphisms on human 5-HT3AB receptor expression and signalling.

Krzywkowski K, Davies PA, Irving AJ, Bräuner-Osborne H, Jensen AA.

Pharmacogenet Genomics. 2008 Dec;18(12):1027-40. doi: 10.1097/FPC.0b013e328310f950.

PMID:
19008750
9.

The 5-hydroxytryptamine type 3 (5-HT3) receptor reveals a novel determinant of single-channel conductance.

Peters JA, Kelley SP, Dunlop JI, Kirkness EF, Hales TG, Lambert JJ.

Biochem Soc Trans. 2004 Jun;32(Pt3):547-52. Review.

PMID:
15157181
10.

Importance of the C-terminus of the human 5-HT3A receptor subunit.

Butler AS, Lindesay SA, Dover TJ, Kennedy MD, Patchell VB, Levine BA, Hope AG, Barnes NM.

Neuropharmacology. 2009 Jan;56(1):292-302. doi: 10.1016/j.neuropharm.2008.08.017. Epub 2008 Aug 22.

PMID:
18786552
11.

The 5-HT3B subunit is a major determinant of serotonin-receptor function.

Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF.

Nature. 1999 Jan 28;397(6717):359-63.

PMID:
9950429
12.

Length and amino acid sequence of peptides substituted for the 5-HT3A receptor M3M4 loop may affect channel expression and desensitization.

McKinnon NK, Bali M, Akabas MH.

PLoS One. 2012;7(4):e35563. doi: 10.1371/journal.pone.0035563. Epub 2012 Apr 23.

13.
14.

Identification of domains influencing assembly and ion channel properties in alpha 7 nicotinic receptor and 5-HT3 receptor subunit chimaeras.

Gee VJ, Kracun S, Cooper ST, Gibb AJ, Millar NS.

Br J Pharmacol. 2007 Oct;152(4):501-12. Epub 2007 Aug 27.

15.

The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphine.

Baptista-Hon DT, Deeb TZ, Othman NA, Sharp D, Hales TG.

Br J Pharmacol. 2012 Feb;165(3):693-704. doi: 10.1111/j.1476-5381.2011.01582.x.

16.

Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression.

Krzywkowski K, Jensen AA, Connolly CN, Bräuner-Osborne H.

Pharmacogenet Genomics. 2007 Apr;17(4):255-66. Erratum in: Pharmacogenet Genomics. 2007 Jun;17(6):459.

PMID:
17496724
17.

Modified 5-HT3A receptor function by co-expression of alternatively spliced human 5-HT3A receptor isoforms.

Brüss M, Barann M, Hayer-Zillgen M, Eucker T, Göthert M, Bönisch H.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):392-401.

PMID:
11111833
18.

The C and E subunits of the serotonin 5-HT3 receptor subtly modulate electrical properties of the receptor.

Yaakob NS, Nguyen DT, Exintaris B, Irving HR.

Biomed Pharmacother. 2018 Jan;97:1701-1709. doi: 10.1016/j.biopha.2017.12.010. Epub 2017 Dec 8.

PMID:
29793334
19.

The 5-HT3B subunit confers spontaneous channel opening and altered ligand properties of the 5-HT3 receptor.

Hu XQ, Peoples RW.

J Biol Chem. 2008 Mar 14;283(11):6826-31. doi: 10.1074/jbc.M707571200. Epub 2008 Jan 10.

20.

Yokukansan contains compounds that antagonize the 5-HT3 receptor.

Nakamura Y, Ishida Y, Kondo M, Shimada S.

Phytomedicine. 2018 Apr 1;43:120-125. doi: 10.1016/j.phymed.2018.04.034. Epub 2018 Apr 16.

PMID:
29747744

Supplemental Content

Support Center